ATE477015T1

Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device

Abstract

A method and device for delivering ventricular resynchronization pacing therapy in conjunction with electrical stimulation of nerves which alter the activity of the autonomic nervous system is disclosed. Such therapies may be delivered by an implantable device and are useful in preventing the deleterious ventricular remodeling which occurs as a result of a heart attack or heart failure. The device may perform an assessment of cardiac function in order to individually modulate the delivery of the two types of therapy.

Term

Term ended

Projected expiry passed 20 May 2025, 1.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

16 members in 6 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
85034104United States of AmericaA
2005017659United States of AmericaW

Members16

Family members, oldest first
DocumentOfficeKind
US2005261741A1United States of AmericaA1
WO2005113066A1World Intellectual Property Organization (WIPO)A1
EP1761305A1European Patent Office (EPO)A1
US7260431B2United States of AmericaB2
JP2007537840AJapanA
US2008015648A1United States of AmericaA1
EP1761305B1European Patent Office (EPO)B1
AT477015TAustriaT
ATE477015T1This recordAustriaT1
DE602005022865D1GermanyD1
US7805193B2United States of AmericaB2
US2011015692A1United States of AmericaA1
JP4731559B2JapanB2
US8483828B2United States of AmericaB2
US2013296958A1United States of AmericaA1
US8838239B2United States of AmericaB2